Promoting R&D Activities Through Open Innovation, Collaboration & Partnership
Sysmex RDCA embraces open innovation – integration of internal and external knowledge, ideas and technologies – which enables it to accelerate new clinical value generation. Our R&D activities are aimed at the development of “new applications for existing platforms” and “new elemental technologies” based on open innovation collaborations. RDCA laboratories are well equipped with principal analytical instruments for our state-of-the-art platforms so that efficient and effective research and development can be realized.
If you have a new biomarker or a new technology that you would like to introduce to Sysmex RDCA, please contact us.
RDCA Laboratories
Our laboratories have capabilities for any evaluations and investigations regarding cell, protein, and gene analysis with principal analytical instruments and our state-of-the-art platforms.
Protein Lab
The protein lab is fully equipped for assay development (from ELISA testing systems to our ultrasensitive immunoassay platform), protein characterization, fragmentation, purification, labeling, and quantitation. We are working on technologies to detect proteins in blood and urine at high speeds and with a high degree of precision. The lab is also equipped with a brand-new exosome counter* developed by JVC Kenwood. (*Sysmex group is jointly developing a diagnostic device for exosomes with JVC Kenwood.)
Principal Instruments:
- Ultrasensitive Immunoassay System
- Automated Immunoassay System
- Digital Exosome counting system*
- HPLC system
- ELISA testing system
*Sysmex group is jointly developing a diagnostic instrument for exosomes with JVC Kenwood.
Cell Lab
MI-1000 – Molecular Imaging Flow Cytometry
The cell lab is equipped with both conventional flow cytometry (FCM) and our state-of-the-art molecular imaging FCM platforms. We are working on technologies to allow the specific detection of nucleic acids, organelles, and other elements within cells, as well as the detection of in-cell protein locations and chromosomal aberrations.
Principal Instruments:
- Molecular Imaging Flow Cytometer
- Automated Hematology Analyzer
- Conventional flow cytometry
Gene Lab
The gene lab is equipped to handle conventional PCR and next generation sequencing. We are working on technologies to enable genomic quantification of cancer cells as well as the detection of circulating cancer cell-derived DNA.
Principal Instruments:
- Next-generation Sequencer
- Thermal Cycler
Collaborators
We are welcoming collaborators to enhance technologies contributing to healthcare advancement.
